(Q39279368)

10 September 2017

title

Small Intestinal Release Mesalamine for the Treatment of Refractory Celiac Disease Type I (English)

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

20 July 2024

author name string

Shailaja Jamma

1

1 reference

10 September 2017

Melinda Dennis

3

1 reference

10 September 2017

Sunil Sheth

6

1 reference

10 September 2017

Daniel A. Leffler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20871406

20 July 2024

Robert M. Najarian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20871406

20 July 2024

Detlef B. Schuppan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20871406

20 July 2024

Ciaran P. Kelly

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20871406

20 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20871406

20 July 2024

publication date

1 January 2011

1 reference

full work available at URL

10 September 2017

https://journals.lww.com/10.1097/MCG.0b013e3181f42401

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Journal of Clinical Gastroenterology

20 July 2024

published in

1 reference

10 September 2017

volume

45

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

30-33

1 reference

Current concepts of celiac disease pathogenesis

10 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

20 July 2024

Celiac Disease

2

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Refractory celiac disease

20 July 2024

3

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.

20 July 2024

5

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.

20 July 2024

6

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience

20 July 2024

7

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Azathioprine in refractory sprue: results from a prospective, open-label study

20 July 2024

8

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot study

20 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Budesonide in the treatment of refractory celiac disease.

20 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Therapy with budesonide in patients with refractory sprue

20 July 2024

11

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy

20 July 2024

12

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Review article: the mode of action of the aminosalicylates in inflammatory bowel disease.

20 July 2024

13

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Etiologies and predictors of diagnosis in nonresponsive celiac disease

20 July 2024

14

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma

20 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.

20 July 2024

16

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.

20 July 2024

17

1 reference

https://api.crossref.org/works/10.1097/MCG.0B013E3181F42401

20 July 2024

Identifiers

1 reference

10 September 2017

1 reference